Inventor
YANG DEXI
US15 patents
⚠️ This page may combine multiple inventors who share the name “YANG DEXI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME LLC
8 patentsUS12331018B2Jun 17, 2025
Pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC1 citations63
US12552767B2Feb 17, 2026
3-heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US12497362B2Dec 16, 2025
Cyclopentapyrrole orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations51
US12492187B2Dec 9, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations49
US12304899B2May 20, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations49
US11680060B2Jun 20, 2023
Bicycloheptane pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations49
US12428397B2Sep 30, 2025
Factor XI activation inhibitors
MERCK SHARP & DOHME LLC0 citations48
US12312332B2May 27, 2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
MERCK SHARP & DOHME LLC0 citations48
MERCK SHARP & DOHME
7 patentsUS10544130B2Jan 28, 2020
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME1 citations73
US10221163B2Mar 5, 2019
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME4 citations73
US9839642B2Dec 12, 2017
Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME3 citations72
US9708336B2Jul 18, 2017
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME4 citations70
US11207312B2Dec 28, 2021
Metallo-beta-lactamase inhibitors and methods of use thereof
MERCK SHARP & DOHME0 citations62
US10227331B2Mar 12, 2019
Metallo-β-lactamase inhibitors
MERCK SHARP & DOHME1 citations62
US11098029B2Aug 24, 2021
5-alkyl pyrrolidine orexin receptor agonists
MERCK SHARP & DOHME1 citations60